Wolverine Trading, LLC Nymox Pharmaceutical Corp Call Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$1.3 - $2.23 $27,560 - $47,276	-21,200 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.46 - $2.48 $13,870 - $23,560	9,500 Added 81.2%	21,200 $33,000
Q2 2020 Aug 13, 2020	SELL	$2.1 - $4.6 $8,610 - $18,860	-4,100 Reduced 25.95%	11,700 $41,000
Q1 2020 May 11, 2020	BUY	$1.69 - $3.88 $26,702 - $61,304	15,800 New	15,800 $34,000
Q3 2019 Nov 14, 2019	SELL	$1.41 - $2.12 $15,933 - $23,956	-11,300 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$1.33 - $2.12 $931 - $1,484	-700 Reduced 5.83%	11,300 $16,000
Q1 2019 May 15, 2019	SELL	$1.57 - $2.71 $39,878 - $68,834	-25,400 Reduced 67.91%	12,000 $24,000
Q1 2018 May 15, 2018	BUY	$3.09 - $4.43 $7,725 - $11,075	2,500 Added 7.16%	37,400 $158,000
Q4 2017 Feb 14, 2018	SELL	$3.29 - $4.06 $18,753 - $23,141	-5,700 Reduced 14.04%	34,900 $115,000
Q3 2017 Nov 15, 2017	BUY	$3.36 - $4.02 $136,416 - $163,211	40,600	40,600 $155,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.